IMV Inc. (IMVIQ)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 10:13AM EDT
| Previous close | 0.0000 |
| Open | 0.0000 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.0000 - 0.0000 |
| 52-week range | 0.0000 - 0.8225 |
| Volume | |
| Avg. volume | 1,015 |
| Market cap | 11 |
| Beta (5Y monthly) | 0.75 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.5500 |
| Earnings date | 14 Mar 2024 - 18 Mar 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 5.00 |
Business WireIMV Accepts an Offer from its Secured Lenders for the Sale of its Intellectual Property Assets
DARTMOUTH, Nova Scotia, September 01, 2023--IMV Inc. (the "Company" or "IMV") announces today that it has accepted an offer (the "Offer") from IMV’s largest secured creditors (the "Secured Lenders"), pursuant to which IMV and its subsidiary, Immunovaccine Technologies Inc. have agreed to sell to the Secured Lenders its intellectual property assets (the "Transaction") in consideration for a partial reduction of debt owing to the Secured Lenders.
Business WireIMV Inc. Announces Update on CCAA Proceedings and Sales and Investment Solicitation Process
DARTMOUTH, Nova Scotia, July 26, 2023--IMV Inc. (the "Company" or "IMV"), recently announced an update on the Sales and Investment Solicitation Process (the "SISP") implemented as part of its ongoing proceedings under the Companies' Creditors Arrangement Act (the "CCAA").
© 2024 Yahoo. All rights reserved.